Rockefeller Capital Management L.P. Novavax Inc Transaction History

Rockefeller Capital Management L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$18.2 - $76.12 $4,422 - $18,497	-243 Reduced 15.42%	1,333 $24,000
Q2 2022 Aug 12, 2022	BUY	$36.28 - $75.29 $44,987 - $93,359	1,240 Added 369.05%	1,576 $81,000
Q1 2022 May 13, 2022	SELL	$69.73 - $142.9 $3,486 - $7,145	-50 Reduced 12.95%	336 $24,000
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $20,049 - $32,477	149 Added 62.87%	386 $55,000
Q3 2021 Nov 12, 2021	SELL	$177.8 - $270.58 $355 - $541	-2 Reduced 0.84%	237 $49,000
Q2 2021 Aug 10, 2021	BUY	$121.0 - $257.67 $363 - $773	3 Added 1.27%	239 $50,000
Q1 2021 May 11, 2021	BUY	$112.98 - $319.93 $3,163 - $8,958	28 Added 13.46%	236 $42,000
Q4 2020 Feb 12, 2021	BUY	$78.74 - $139.5 $16,377 - $29,016	208 New	208 $23,000
Q2 2020 Aug 12, 2020	SELL	$13.86 - $83.61 $3,257 - $19,648	-235 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$3.93 - $16.0 $923 - $3,760	235 New	235 $3,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.